BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22443116)

  • 1. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.
    Lescaille G; Menashi S; Cavelier-Balloy B; Khayati F; Quemener C; Podgorniak MP; Naïmi B; Calvo F; Lebbe C; Mourah S
    BMC Cancer; 2012 Mar; 12():115. PubMed ID: 22443116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
    Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines.
    Shiratsuchi T; Ishibashi H; Shirasuna K
    J Cell Physiol; 2002 Dec; 193(3):340-8. PubMed ID: 12384986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis.
    Nozaki S; Endo Y; Kawashiri S; Nakagawa K; Yamamoto E; Yonemura Y; Sasaki T
    Oral Oncol; 1998 Jan; 34(1):58-62. PubMed ID: 9659521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells.
    Dil N; Banerjee AG
    Head Neck Oncol; 2011 Sep; 3():44. PubMed ID: 21958730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of emmprin by oral squamous cell carcinoma.
    Bordador LC; Li X; Toole B; Chen B; Regezi J; Zardi L; Hu Y; Ramos DM
    Int J Cancer; 2000 Feb; 85(3):347-52. PubMed ID: 10652425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
    Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
    BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
    Ghosh S; Munshi HG; Sen R; Linz-McGillem LA; Goldman RD; Lorch J; Green KJ; Jones JC; Stack MS
    Cancer; 2002 Dec; 95(12):2524-33. PubMed ID: 12467066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of urokinase-type plasminogen activator in oral squamous cell carcinoma].
    Liang X; Mao Z; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):147-9. PubMed ID: 12838705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.
    Huang Z; Tan N; Guo W; Wang L; Li H; Zhang T; Liu X; Xu Q; Li J; Guo Z
    PLoS One; 2014; 9(4):e91596. PubMed ID: 24705283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
    Panich T; Tragoolpua K; Pata S; Tayapiwatana C; Intasai N
    Cancer Biother Radiopharm; 2017 Feb; 32(1):1-8. PubMed ID: 28118037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urokinase-type plasminogen activator (uPA) and its inhibitor--new prognostic factors in oral squamous cell carcinoma].
    Geleţu G; Plămădeală P; Gogălniceanu D; Zeilhofer HF; Popescu E; Moscalu M
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):79-84. PubMed ID: 15688761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.
    Alam H; Bhate AV; Gangadaran P; Sawant SS; Salot S; Sehgal L; Dange PP; Chaukar DA; D'cruz AK; Kannanl S; Gude R; Kane S; Dalal SN; Vaidya MM
    BMC Cancer; 2012 Jan; 12():32. PubMed ID: 22264292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIEN1 promotes oral cancer progression and implicates poor overall survival.
    Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
    Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa.
    Pasini FS; Brentani MM; Kowalski LP; Federico MH
    Head Neck; 2001 Sep; 23(9):725-32. PubMed ID: 11505481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer.
    Sharwani A; Jerjes W; Hopper C; Lewis MP; El-Maaytah M; Khalil HS; Macrobert AJ; Upile T; Salih V
    Arch Oral Biol; 2006 Dec; 51(12):1104-11. PubMed ID: 16889746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
    Luparello C; Sirchia R; Pupello D
    J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells.
    Liu G; Shuman MA; Cohen RL
    Int J Cancer; 1995 Feb; 60(4):501-6. PubMed ID: 7829264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.